The role of sclerostin and irisin on bone and muscle of orchiectomized rats

Author:

Zhou Bing-na1,Zhang Qian1,Lin Xiao-yun1,Hu Jing1,Zhao Di-chen1,Jiang Yan1,Xing Xiao-ping1,Li Mei1

Affiliation:

1. Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Abstract Background: The reduction in androgen level gives rise to a decrease in bone mineral density and muscle strength,but the exact mechanisms are unclear. We investigated the roles of novel cytokines of sclerostin and irisin on bone and muscle of orchiectomized (ORX) rats. Methods: Twenty 3-month-old male rats were randomized to receive sham or orchiectomy operation. Rats were euthanized after 8 weeks of surgery, and serum levels of sclerostin and irisin were measured by enzyme-linked immunosorbent assay at baseline and execution. Grip strength was measured by a grip strength tester at baseline and before execution. Bone mineral density (BMD) and bone microarchitecture were measured by microcomputed tomography. The samples of bone and muscle were harvested at execution. Bone biomechanics were measured by three-point bending tests and vertebral body indentation tests. Bone and muscle histological features were analyzed by hematoxylin and eosin stain, Von Kossa’s stain and tartrate resistant acid phosphatase stain. Simple linear regression analyses were used to analyze the relationships between serum levels of sclerostin, irisin and grip strength and BMD of ORX rats. Results: Serum sclerostin level increased from 279±44 pg/mL to 586±57 pg/mL since baseline to 8 weeks after ORX (P=0.002), which was significantly higher than that in sham rats (406±20 pg/mL at execution) (P=0.012). The serum irisin level decreased from 4.12±0.20 ng/mL to 3.55±0.29 ng/mL since baseline to 8 weeks of ORX (P=0.048), which was significantly lower than sham rats (4.84±0.37 pg/mL at execution) (P=0.013). Trabecular BMD, parameters of bone microarchitecture, bone strength, grip strength and the myofibers size of soleus muscles were significantly lower in ORX rats than in sham group. Grip strength was positively correlated with femoral trabecular BMD (r=0.713, P<0.001) and bone volume/total volume (r=0.712, P<0.001) in all rats. The serum sclerostin level was negatively correlated to femoral trabecular BMD (r=-0.508, P=0.022) and grip strength (r=-0.492, P=0.028). Serum irisin level was positively correlated with femoral trabecular BMD (r=0.597, P=0.005), but no obvious correlation was found between irisin level and muscle strength in all rats. Conclusions: Reduced BMD, impaired bone microarchitecture, weak strength of bone and muscle, and thin myofibers were induced by androgen deficiency of ORX rats. Serum sclerostin and irisin levels were significantly changed after ORX, which might be closely correlated with the occurrence of osteoporosis and sarcopenia in ORX rats.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Osteoporosis;Ensrud KE;Ann Intern Med,2017

2. Cruz-Jentoft AJ, Sayer AA: Sarcopenia. Lancet (London, England) 2019, 393(10191):2636–2646.

3. Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease;Carson JA;Bone,2015

4. Skinner JW, Otzel DM, Bowser A, Nargi D, Agarwal S, Peterson MD, Zou B, Borst SE, Yarrow JF: Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis. Journal of cachexia, sarcopenia and muscle 2018, 9(3):465–481.

5. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice;Vidal O;Proc Natl Acad Sci USA,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3